mortality risk – Medxy AI

Obesity Linked to Three-Fold Increase in Severe Infection Risk: A Global Analysis of 925 Pathogens

By MedXY 02/15/2026

A large-scale multicohort study reveals that adult obesity significantly increases the risk of hospitalization and death across nearly 1,000 infectious diseases, accounting for approximately one in ten infection-related deaths globally.

Internal Medicine news Nursing & care

Cumulative Geriatric Syndrome Burden: A Potent Predictor of 90-Day Mortality in Hospitalized Older Adults

By MedXY 02/10/2026

A large multicenter cohort study demonstrates that the number of geriatric syndromes at hospital admission is independently and incrementally associated with 90-day mortality, suggesting that cumulative geriatric burden is a critical prognostic indicator beyond traditional disease-centric models.

Neurology news Pediatrics

The Mortality Gap in Neurodevelopmental Care: Why Young Adults with ASD, ID, and CP Face Higher Risks

By MedXY 02/10/2026

A landmark study using CDC ADDM Network data reveals significantly elevated mortality risks for young adults with autism, intellectual disability, and cerebral palsy, highlighting a critical need for improved transition-of-care strategies and better clinical surveillance.

Cardiology Emergency Medicine news

The Price of Time: 20-Year Study Reveals Pre-Hospital Delay as a Critical Driver of STEMI Mortality

By MedXY 01/03/2026

A 20-year analysis of 89,155 patients from the SWEDEHEART registry confirms that pre-hospital delay independently predicts short- and long-term mortality. Despite advances in reperfusion, women, elderly patients, and those with diabetes consistently experience significantly longer delays, highlighting a critical need for targeted public health interventions.

Diabetes & Endocrinology Internal Medicine news

Handgrip Strength as a Predictor of Preclinical Obesity Progression and Mortality: Insights from the UK Biobank Multistate Model Analysis

By MedXY 10/29/2025

This study reveals that higher handgrip strength is significantly associated with reduced risks of preclinical obesity progression and mortality, highlighting the importance of muscle strength in managing early obesity-related health risks.

Diabetes & Endocrinology news Public Health

Disentangling Clinical and Preclinical Obesity: Their Distinct Impacts on All-Cause Mortality Risk in the UK Biobank Study

By MedXY 10/29/2025

New evidence from the UK Biobank reveals that clinical obesity, defined by obesity-related dysfunctions, significantly elevates all-cause mortality risk. Early detection and intervention are key to reducing mortality associated with both preclinical and clinical obesity.

Cardiology Pediatrics Specialties

Early Childhood High Blood Pressure Predicts Premature Cardiovascular Mortality: Insights from a 50-Year Longitudinal US Cohort

By MedXY 09/07/2025

Elevated blood pressure at age 7 significantly increases the risk of premature cardiovascular mortality by mid-adulthood, underscoring the need for early-life blood pressure monitoring and intervention.

Family Medicine & Nutrition Internal Medicine news Specialties

Sitting-Rising Test and Single-Leg Balance: Simple yet Powerful Predictors of Longevity and Aging

By MedXY 08/23/2025

A simple sitting-rising test (SRT) and single-leg standing time can powerfully predict mortality risk and reflect neuromuscular aging, offering a low-cost method to assess health in middle-aged and older adults.

Neurology news Specialties

Association of Medication Use and 8-Year Mortality Risk in Patients With Parkinson Disease

By MedXY 08/17/2025

This study explores medication use and its impact on 8-year mortality among patients with Parkinson disease, identifying potential drug repurposing candidates for treatment.

Clinical Updates Diabetes & Endocrinology news Specialties Urology

SGLT2 Inhibitors Lower Mortality Risk Post-UTI in Diabetes

By MedXY 08/14/2025

Recent research indicates that patients with type 2 diabetes who use SGLT2 inhibitors after a urinary tract infection have a lower mortality risk compared to those using DPP-4 inhibitors.